Johnson & Johnson stock gains on July quarter and guidance

Published on 09/18/2026 at 13:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock ended the recent session at USD 270.22 on September 17, 2026. July quarter EPS was USD 2.90 and revenue reached USD 25.31 billion.

Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground — Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

Johnson & Johnson stock (ISIN US4781601046) closed at USD 270.22 on September 17, 2026, after a 1.1 percent rise from the prior session, and the latest reported quarter brought USD 2.90 in EPS on USD 25.31 billion in revenue.

July quarter still drives the story

According to MarketBeat, Johnson & Johnson last posted quarterly earnings on July 15, 2026, with EPS of USD 2.90, above the USD 2.84 consensus by USD 0.06. The same report put revenue at USD 25.31 billion, up 6.6 percent from a year earlier, while net margin reached 21.48 percent.

That comparison matters for the stock because the guidance for fiscal 2026 still points to EPS of USD 11.60 to USD 11.75, and analysts on the same data set expect USD 11.61 for the year. The spread is tiny, so the market is watching whether the company can turn the July beat into a stronger full-year run.

Analysts stay constructive

According to MarketBeat, UBS Group began coverage on September 2, 2026 with a Buy rating and a USD 320 price target, while HSBC lifted its target from USD 290 to USD 320 on September 10, 2026 and also kept a Buy view. The same source says the consensus rating is Moderate Buy with a consensus price target of USD 274.13.

For investors, that leaves the share price only slightly below the consensus target, but still far from the higher end of the Street's range. The highest target in the cited set is USD 320, which frames how much upside the current valuation already discounts.

Stock near the range high

Johnson & Johnson stock traded at USD 270.26 on September 18, 2026, with a market capitalization of USD 643.92 billion and a 52-week range of USD 173.33 to USD 281.07, according to MEXC data. The stock is trading less than 4 percent below that high, which keeps chart watchers focused on the USD 281 area.